References
- Zinkernagel RM. Immunology taught by viruses. Science 1996; 271:173 - 8; http://dx.doi.org/10.1126/science.271.5246.173; PMID: 8539616
- Rao RR, Li Q, Odunsi K, Shrikant PA. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity 2010; 32:67 - 78; http://dx.doi.org/10.1016/j.immuni.2009.10.010; PMID: 20060330
- Araki K, Turner AP, Shaffer VO, Gangappa S, Keller SA, Bachmann MF, et al. mTOR regulates memory CD8 T-cell differentiation. Nature 2009; 460:108 - 12; http://dx.doi.org/10.1038/nature08155; PMID: 19543266
- Li Q, Rao RR, Araki K, Pollizzi K, Odunsi K, Powell JD, et al. A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity. Immunity 2011; 34:541 - 53; http://dx.doi.org/10.1016/j.immuni.2011.04.006; PMID: 21511183
- Colombetti S, Basso V, Mueller DL, Mondino A. Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin. J Immunol 2006; 176:2730 - 8; PMID: 16493028
- Powell JD, Lerner CG, Schwartz RH. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. J Immunol 1999; 162:2775 - 84; PMID: 10072524
- Kang J, Huddleston SJ, Fraser JM, Khoruts A. De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR. J Leukoc Biol 2008; 83:1230 - 9; http://dx.doi.org/10.1189/jlb.1207851; PMID: 18270248
- Odunsi K, Matsuzaki J, Karbach J, Neumann A, Mhawech-Fauceglia P, Miller A, et al. Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients. Proc Natl Acad Sci U S A 2012; 109:5797 - 802; http://dx.doi.org/10.1073/pnas.1117208109; PMID: 22454499
- Li Q, Rao R, Vazzana J, Goedegebuure P, Odunsi K, Gillanders W, et al. Regulating mammalian target of rapamycin to tune vaccination-induced CD8(+) T cell responses for tumor immunity. J Immunol 2012; 188:3080 - 7; http://dx.doi.org/10.4049/jimmunol.1103365; PMID: 22379028
- Lamming DW, Ye L, Katajisto P, Goncalves MD, Saitoh M, Stevens DM, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 2012; 335:1638 - 43; http://dx.doi.org/10.1126/science.1215135; PMID: 22461615